Nova Submits Phase II A Psilocybin Clinical Trial Application to Health Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. REAX
10. RMAX

Go back to Nova Submits Phase II A Psilocybin Clinical Trial Application to Health Canada
(AMEX: NMLSF) Delayed: 0.06 --0 (-0%)
Previous Close $0.06    52 Week High $ 
Open $0.06    52 Week Low $ 
Day High $0.06    P/E N/A 
Day Low $0.06    EPS $ 
Volume 37,727